125 related articles for article (PubMed ID: 27478135)
21. Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populations.
Shilbayeh S; Tutunji MF
Clin Pharmacokinet; 2006; 45(6):593-610. PubMed ID: 16719541
[TBL] [Abstract][Full Text] [Related]
22. Omeprazole absorption from a compounded transdermal formulation in healthy volunteers.
Haas CE; Lin L; Cloen D; Kufel T; Moon R; Frerichs V
J Am Pharm Assoc (2003); 2005; 45(4):473-8. PubMed ID: 16128503
[TBL] [Abstract][Full Text] [Related]
23. Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.
Chen BL; Chen Y; Tu JH; Li YL; Zhang W; Li Q; Fan L; Tan ZR; Hu DL; Wang D; Wang LS; Ouyang DS; Zhou HH
J Clin Pharmacol; 2009 May; 49(5):574-81. PubMed ID: 19398604
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores.
Raidal SL; Andrews FM; Nielsen SG; Trope G
Equine Vet J; 2017 Nov; 49(6):802-809. PubMed ID: 28432741
[TBL] [Abstract][Full Text] [Related]
25. Effect of protein source on nitrogen balance and plasma amino acids in exercising horses.
Graham-Thiers PM; Bowen LK
J Anim Sci; 2011 Mar; 89(3):729-35. PubMed ID: 21075968
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of omeprazole powder paste or enteric-coated formulation in healing of gastric ulcers in horses.
Birkmann K; Junge HK; Maischberger E; Wehrli Eser M; Schwarzwald CC
J Vet Intern Med; 2014; 28(3):925-33. PubMed ID: 24628650
[TBL] [Abstract][Full Text] [Related]
27. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
Joti JJ; Nahar K; Hasan A; Azad MA; Ullah MA; Islam SM; Hasnat A
Arzneimittelforschung; 2009; 59(4):171-5. PubMed ID: 19517893
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules.
Amer F; Karol MD; Pan WJ; Griffin JS; Lukasik NL; Locke CS; Chiu YL
Clin Ther; 2004 Dec; 26(12):2076-83. PubMed ID: 15823771
[TBL] [Abstract][Full Text] [Related]
29. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
Larson C; Cavuto NJ; Flockhart DA; Weinberg RB
Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours.
Lee DY; Shin HS; Lee I; Lee MG
Biopharm Drug Dispos; 2006 Nov; 27(8):361-70. PubMed ID: 16894645
[TBL] [Abstract][Full Text] [Related]
31. Advanced method for determination of omeprazole in plasma by HPLC.
Kang WK; Kim DS; Kwon KI
Arch Pharm Res; 1999 Feb; 22(1):86-8. PubMed ID: 10071967
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and physiological effects of repeated oral administrations of tramadol in horses.
Guedes AG; Knych HK; Soares JH; Brosnan RJ
J Vet Pharmacol Ther; 2014 Jun; 37(3):269-78. PubMed ID: 24180699
[TBL] [Abstract][Full Text] [Related]
33. Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods.
Chun AH; Erdman K; Zhang Y; Achari R; Cavanaugh JH
Clin Ther; 2000 Feb; 22(2):231-6. PubMed ID: 10743982
[TBL] [Abstract][Full Text] [Related]
34. Effect of omeprazole paste on gastric acid secretion in horses.
Daurio CP; Holste JE; Andrews FM; Merritt AM; Blackford JT; Dolz F; Thompson DR
Equine Vet J Suppl; 1999 Apr; (29):59-62. PubMed ID: 10696296
[TBL] [Abstract][Full Text] [Related]
35. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers.
Calabresi L; Pazzucconi F; Ferrara S; Di Paolo A; Tacca MD; Sirtori C
Pharmacol Res; 2004 May; 49(5):493-9. PubMed ID: 14998561
[TBL] [Abstract][Full Text] [Related]
37. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of antiulcer agents in llama.
Christensen JM; Limsakun T; Smith BB; Hollingshead N; Huber M
J Vet Pharmacol Ther; 2001 Feb; 24(1):23-33. PubMed ID: 11348484
[TBL] [Abstract][Full Text] [Related]
39. The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.
Junghard O; Hassan-Alin M; Hasselgren G
Eur J Clin Pharmacol; 2002 Oct; 58(7):453-8. PubMed ID: 12389067
[TBL] [Abstract][Full Text] [Related]
40. A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.
Sykes BW; Sykes KM; Hallowell GD
Equine Vet J; 2014 Jul; 46(4):416-21. PubMed ID: 24102898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
